Real-world analysis of peptide receptor radionuclide therapy (PRRT) in the treatment of neuroendocrine tumors.

Justin Chau,Nanmeng Yu,Hirva Bakeri,Yusuf Menda,Joseph S. Dillon,Chandrikha Chandrasekharan

Real-world analysis of peptide receptor radionuclide therapy (PRRT) in the treatment of neuroendocrine tumors.

2020

Justin Chau
Nanmeng Yu
Hirva Bakeri
Yusuf Menda
Joseph S. Dillon
Chandrikha Chandrasekharan

e16701Background: PRRT received FDA approval in 2018 for treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors (GEPNETs) based on NETTER-1 trial data that include...

Keywords:

peptide receptor
radionuclide therapy
Pathology
Neuroendocrine tumors
Cancer research
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations